# Dichotic Listening as a Predictor of Medication Response in Depression

> **NCT00296725** · PHASE1,PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 25 (actual)

## Conditions studied

- Major Depression
- Dysthymia
- Depressive Disorder Not Otherwise Specified

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Imipramine

## Key facts

- **NCT ID:** NCT00296725
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296725, "Dichotic Listening as a Predictor of Medication Response in Depression". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00296725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*